Alligator Bioscience AB (publ) announced that Anette Sundstedt, PhD, Principal Scientist at Alligator, has been appointed as employee representative, and Karin Nordbladh, Director Clinical Operations at Alligator, as deputy employee representative at the Alligator Bioscience AB's Board of Directors, effective July 5, 2023. Anette Sundstedt, who joined Alligator in 2021, replaces Tova Landström, who resigned on May 26, 2023, for personals reasons.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 SEK | -1.64% |
|
+3.27% | +74.17% |
Jul. 11 | Transcript : Alligator Bioscience AB, Q2 2024 Earnings Call, Jul 11, 2024 | |
Jul. 11 | Alligator Bioscience AB Appoints Johan Giléus as Chief Financial Officer as of August 12, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+74.17% | 87.09M | |
+25.83% | 47.96B | |
+0.69% | 42.45B | |
+44.42% | 41.47B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- ATORX Stock
- News Alligator Bioscience AB
- Alligator Bioscience AB Announces Executive Changes